Skip to search formSkip to main contentSkip to account menu

Amphocil

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Amphotericin B
Fungizoneamphotericin B liposomal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.
Review
2003
Review
2003
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
The leishmaniases are protozoan diseases caused by Leishmania parasites. The first‐line treatment of its visceral forms is… 
2003
2003
Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration.
OBJECTIVES The pharmacokinetics of lipid-formulated amphotericin B (AMB), and of AMB that has dissociated from its lipid moiety… 
Review
2001
Review
2001
Lipid-based amphotericin B: a review of the last 10 years of use.
Review
2001
Review
2001
Lipid-based antifungal agents: current status.
Immunocompromised patients are well known to be predisposed to developing invasive fungal infections. These infections are… 
1999
1999
In vitro and in vivo activity of amphotericin B-lipid formulations against experimental Trypanosoma cruzi infections.
The activities of four amphotericin B formulations, Fungizone, AmBisome, Amphocil, and Abelcet, were compared in vitro and in… 
Highly Cited
1998
Highly Cited
1998
Visceral Leishmaniasis in the BALB/c Mouse: A Comparison of the Efficacy of a Nonionic Surfactant Formulation of Sodium Stibogluconate with Those of Three Proprietary Formulations of Amphotericin B
ABSTRACT In this study, treatment efficacies of a nonionic surfactant vesicle formulation of sodium stibogluconate (SSG-NIV) and… 
Highly Cited
1997
Highly Cited
1997
Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis
The antileishmanial efficacies of four proprietary amphotericin B (AmB) formulations (Fungizone, AmBisome, Abelcet, and Amphocil… 
Highly Cited
1996
Highly Cited
1996
Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant.
Amphotericin B colloidal dispersion (ABCD; Amphocil) was evaluated in a phase I dose-escalation study in 75 marrow transplant… 
1996
1996
Amphotéricine B désoxycholate (Fungizone®): vieux médicament, nouvelles versions
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)